NEW YORK, March 17 (GenomeWeb News) - Acceler8's second-quarter fiscal 2005 net revenues jumped 654 percent to $241,946, from $36,968 in the same quarter in the previous year, the company said today.

 

The company's net loss narrowed from $474,341, or $.04 per share, in the second quarter of 2005 to $359,527, or $.03 per share, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.